XML 79 R61.htm IDEA: XBRL DOCUMENT v3.19.2
Earnings (Loss) Per Share (Details) - USD ($)
$ / shares in Units, shares in Millions, $ in Millions
3 Months Ended 6 Months Ended
Jun. 30, 2019
Jun. 30, 2018
Jun. 30, 2019
Jun. 30, 2018
Earnings Per Share, Basic and Diluted [Line Items]        
Antidilutive securities excluded from computation of EPS (in shares) 23.3 15.3 19.3 14.3
Numerator for earnings (loss) per share calculation:        
Income (loss) from continuing operations $ 1,931 $ (2,562) $ 3,358 $ (1,564)
Income from continuing operations allocated to participating securities (1) (1) (3) (3)
Net (income) loss attributable to noncontrolling interests 5 0 (1) 0
Income (loss) from continuing operations attributable to CVS Health $ 1,935 $ (2,563) $ 3,354 $ (1,567)
Denominator for earnings (loss) per share calculation:        
Weighted average shares outstanding, basic (in shares) 1,301.0 1,018.0 1,299.0 1,017.0
Dilutive effect of outstanding stock-based compensation awards (in shares) 1.0 0.0 3.0 0.0
Weighted average shares outstanding, diluted (in shares) 1,302.0 1,018.0 1,302.0 1,017.0
Earnings (loss) per share from continuing operations:        
Income (loss) from continuing operations attributable to CVS Health, basic (in dollars per share) $ 1.49 $ (2.52) $ 2.58 $ (1.54)
Income (loss) from continuing operations attributable to CVS Health, diluted (in dollars per share) $ 1.49 $ (2.52) $ 2.58 $ (1.54)
Continuing Operations        
Earnings Per Share, Basic and Diluted [Line Items]        
Antidilutive securities excluded from computation of EPS (in shares)   1.9   2.3